Form 8-K - Current report:
SEC Accession No. 0001213900-25-029440
Filing Date
2025-04-07
Accepted
2025-04-07 16:30:13
Documents
15
Period of Report
2025-04-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0237134-8k_pmgc.htm   iXBRL 8-K 40515
2 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EXEC ea023713401ex10-1_pmgc.htm EX-10.1 17192
3 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CONSULTING AGREEMENT FOR NON-EMPL ea023713401ex10-2_pmgc.htm EX-10.2 20255
  Complete submission text file 0001213900-25-029440.txt   269148

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20250403.xsd EX-101.SCH 3026
5 XBRL LABEL FILE elab-20250403_lab.xml EX-101.LAB 34915
6 XBRL PRESENTATION FILE elab-20250403_pre.xml EX-101.PRE 22796
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0237134-8k_pmgc_htm.xml XML 3963
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25818509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)